TRACKER 6 OCT 2026 · WADA publishes the 2027 Prohibited List, in force January 1, 2027. What changed

Peptides, plainly graded.

What each compound is, what the evidence actually shows, and where it stands with the law today. Every claim sourced and double-checked. No dosing advice. No sellers.

Compounds tracked13
Sources cited30
Sources checked0
Last status change6 Oct

The compare table

Every compound on one grid: what it's claimed to do, how strong the human evidence is, and its status with the FDA and WADA. Filter by goal. Every cell links to its sources.

Open the compare table
CompoundEvidenceFDA
Tirzepatide Approved Approved
Retatrutide Evidence grade A Investigational
BPC-157 Evidence grade C Not approved
KPV Evidence grade D Not approved
Our rule 01We sell nothingNo vendor links, no affiliate codes, no sponsors who sell the compounds we cover.
Our rule 02We don't give dosesMost of these have no tested human dose. We tell you what to ask a prescriber instead.
Our rule 03We show our correctionsEvery page has a public changelog. When we get something wrong, we say so on the page.

The Status Line

A short email the day the FDA, HHS or WADA changes a peptide's status. Nothing else.